Obstetrics and Gynaecology Section DOI : 10.7860/JCDR/2020/43641.13653
Year : 2020 | Month : Apr | Volume : 14 | Issue : 04 Page : QC07 - QC10

Acceptability and Outcome of Cervical Cytology in Postnatal Women and Other Nonpregnant Women in Enugu, Nigeria: A Cross-sectional Study

Kingsley Chukwu Obioha1, Cyril Chukwudi Dim2, Emmanuel Onyebuchi Ugwu3, Chibuike Ogwuegbu Chigbu4, Joseph Tochukwu Enebe5, Benjamin Chukwuma Ozumba6

1 Consultant, Department of Obstetrics and Gynaecology, University of Nigeria Teaching Hospital, Enugu, Nigeria.
2 Professor/Consultant, Department of Obstetrics and Gynaecology, College of Medicine Univerity of Nigeria, Enugu, Nigeria.
3 Reader/Consultant, Department of Obstetrics and Gynaecology, College of Medicine Univerity of Nigeria, Enugu, Nigeria.
4 Senior Lecturer/Consultant, Department of Obstetrics and Gynaecology, College of Medicine Univerity of Nigeria, Enugu, Nigeria.
5 Consultant, Department of Obstetrics and Gynaecology, Enugu State University of Technology Teaching Hospital, Parklane, Enugu, Nigeria.
6 Professor/Consultant, Department of Obstetrics and Gynaecology, College of Medicine Univerity of Nigeria, Enugu, Nigeria.

NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Cyril Chukwudi Dim, Department of Obstetrics and Gynaecology, College of Medicine, University of Nigeria Ituku-Ozalla, Enugu, Nigeria.
E-mail: cyril.dim@unn.edu.ng


Cervical cancer is a leading cause of cancer-related mortality in Sub-Saharan Africa. Although the disease is largely preventable via routine cervical cancer screening, the uptake is ridiculously poor in the sub-region. In Nigeria, current efforts are directed at counselling and screening of eligible women in health care facilities. Therefore, the routine post-natal clinic visit at six weeks postpartum provides a good opportunity to offer cervical cancer screening services.


To compare the acceptability of Pap-test and prevalence of abnormal cervical cytology between post-natal clinic attendees and other non-pregnant women at the University of Nigeria Teaching Hospital Enugu, Nigeria.

Materials and Methods

A cross-divtional analytical study was conducted from January to November 2014 in which acceptability and Pap-test results of 172 women attending the post-natal clinic were compared with an equal number of non-pregnant women from gynaecology and family planning clinics of the hospital. Both groups were selected by systematic sampling method. Outcome measures for each group included the prevalence of abnormal Pap-test and the proportion of women that accepted the Pap-test after appropriate cervical cancer education. Statistical analyses were both descriptive and inferential at 95% confidence level.


Prior to the study, 44.2% (76/172) of participants in postpartum group, and 47.7% (82/172) in control group were aware of Pap-test (p=0.473); while 9.3% (16/172) and 10.5% (18/172) had used Pap-test in the two groups respectively (p=0.718). All participants in each group accepted the Pap-test after cervical cancer education. Prevalence of cervical Squamous Intraepithelial Lesion (SIL) in the postpartum group was similar to that of the control group (OR: 1.8; 95%CI: 0.75-4.10; p=0.21). The most common SIL in both groups was low-grade squamous intraepithelial lesion. There was no statistically significant difference in the distribution of SIL categories (p>0.05).


Acceptability and outcome of Pap-test are similar in post-natal and non-pregnant women in Enugu, Nigeria. Post-natal clinic visit provides an effective opportunity for routine cervical cancer information and screening in Nigeria.


Cervical cancer is a public health concern especially in Africa where it ranks as the most common cause of cancer deaths among women [1]. In Nigeria, based on the 2018 estimates of International Agency for Research on Cancer (IARC), the disease is second to breast cancer in terms of cancer incidence as well as the most common cause of cancer deaths [1]. Notably, cervical carcinoma is about the only human cancer that is almost entirely preventable, and curable when diagnosed at an early stage [2].

The traditional screening method is the Pap-test, and it remains the most successful screening test for cervical carcinoma [2]. Besides early detection of pre-cancerous lesions, the advantages of Pap-test include simplicity, affordability, availability, high sensitivity and specificity. Despite these advantages, the utilisation of this secondary cervical cancer preventive method has remained low in our environment due to several factors that are related to poverty, ignorance, poor health-seeking behaviour, and reduced access to health services [3-5]. Unfortunately, it has been found that a good proportion of women who are aware of Pap-test do not have any reason for not using it [4,6], a situation that has been described as part of the “Not My Portion syndrome” in Nigeria [7].

The World Health Organisation (WHO) recommends Pap-test every 3 years for women between 25-49 years of age, and every 5 years for women over 50 years [2]. Despite this recommendation, there is yet no effective and coordinated cervical cancer screening programme for most low-income countries, including Nigeria [8-11]. Therefore, any opportunity to screen a woman for cervical cancer using Pap-test or any of the recommended methods by the World Health Organisation should be encouraged and utilised effectively [12]. It is known that both the pre-natal and post-natal visits are periods when mothers usually seek health care services for themselves and/or their babies; thus the antenatal and post-natal clinics present great opportunity to introduce other women health care programmes such as cervical cancer information and screening, just as family planning counselling is done during this period. In Norway, where a coordinated National cervical cancer programme exists, Pap-test for antenatal women improved coverage of the preventive health programme [13].

In present environment, however, the six weeks’ postpartum visit, unlike the antenatal period, presents a better opportunity to offer the cervical cancer information and screening without the fear by women that the insertion of instruments into the endocervix might complicate their pregnancies. Moreover, hormonal changes in pregnancy seem to negatively affect endocervical cell yield and accuracy of cervical cytology [14], and also, a high level of spontaneous regression of prenatal cervical pre-invasive lesions occurs postpartum which may favour postpartum screening [15,16]. In Zaria Nigeria, 15.5% and 50% of women diagnosed with low-grade squamous intraepithelial lesion and high-grade intraepithelial lesion respectively during pregnancy had spontaneous reversion to normal cytology at 6 weeks’ postpartum [15]. These raise a concern about the rationale for prenatal Pap-test in a resource-poor setting. Despite this apparent preference for post-natal Pap-test, data on its acceptability by the women in Nigeria is lacking which leaves a knowledge gap. This study was therefore designed to compare the acceptability and results of Pap-test between post-natal and non-pregnant women in Enugu, Nigeria, after a cervical cancer screening education.

Materials and Methods

A cross-sectional analytical study was carried out from January to November 2014. Pap-test results of consenting eligible mothers attending the routine six weeks post-natal clinic (Group A) were compared with those of matched non-pregnant women attending the gynaecology or family planning clinic (Group B) at the University of Nigeria Teaching Hospital (UNTH) Ituku-Ozalla, Enugu, Nigeria. The study was approved by the Ethics committee of the hospital (NHREC/05/01/2008B-FWA00002458-IRB00002323).

A sample size of 172 per group was adequate for the study using an abnormal Pap-test prevalence of 12.2% [17], confidence level of 95%, an error margin of 5%, and attrition rate of 5%.

Inclusion criteria: All apparently healthy women that attended the clinic within the study period were eligible for the study.

Exclusion Criteria: History of cervical cancer, abnormal cervical smear, cervical surgery, or total hysterectomy. The UNTH Enugu is a teaching hospital that offers both primary and specialist health care to residents of Enugu state and neighbouring states of Nigeria. Its, post-natal, gynaecology and family planning clinics are held every weekday.

Thus, for each clinic day, participants in each group were selected by systematic random sampling method, using a sampling interval of three and random start of one until the desired sample size of 172 was achieved. There was individual counselling of each woman recruited for the study. After obtaining informed consent, each participant went through the 4 stages of the study:

In stage 1, each participant’s socio-demographic data, residential addresses and phone numbers, gynaecological and obstetric history, were noted.

In stage 2, the first part of a pre-tested questionnaire consisting of seven structured questions in English language was administered to each participant to ascertain her awareness of cervical cancer, awareness and past use of Pap-test.

In stage 3, each participant was offered information on cervical cancer and its prevention by Pap-test using labelled pictures/diagrams of the normal and cancerous cervix-a strategy referred to as PBCC [7]. This was followed by the administration of the second section of the questionnaire consisting of a structured question, that assessed the participant’s willingness to carry out free Pap-test as part of the study (acceptability of the Pap-test).

Finally, in the 4th stage of the study, Ayre’s spatula and cyto brush were used to collect Pap smear from each participant using the standard method. The smears from each participant were fixed immediately with 95% methyl alcohol.

All smears were processed at the Morbid Anatomy Department of the hospital and analysed by a pathologist blinded to the study objectives. All stages of the study were carried out by the investigators or their research assistants (resident doctors). The assistants were trained on the research objectives, informed consent, confidentially, and Pap smear collection technique.

All the participants were followed-up in the clinics after 2 weeks of specimen collection during which Pap-test results were discussed. Participants, whose results showed no abnormality, were counselled on the need for routine screening, while those with abnormal result were invited for further management.

For this study, abnormal Pap-test was defined as a Pap-test result that showed inflammatory cells or SIL [18], while acceptability of Pap-test referred to the willingness of the participants to undertake the Pap-test herself after appropriate cervical cancer education [19].

Statistical Analysis

Data collected was analysed using the Statistical Package for Social Sciences software version 21 for windows (IBM Corporation). Statistical analyses were both descriptive and inferential at 95% confidence level. Continuous variables were analysed using the mean±2SD where appropriate. Discrete variables were analysed using proportions and Pearson’s chi-square test. A p value of <0.05 was considered as statistically significant.


A total of 173 women per group were recruited for the postpartum (A) and control (B) groups but, 172 women completed the study per group and were analysed giving a completion rate of 99.4%. The age group and educational status for both groups were 31-40 years (44.8% versus 39.5%) and secondary education (51.2% versus 47.7%) respectively [Table/Fig-1]. Prior to the study, 44.2% (76/172) of participants in postpartum group, and 47.7% (82/172) in control group were aware of Pap-test (p=0.473); while only 9.3% (16/172) and 10.5% (18/172) of participants had used Pap-test in the two groups, respectively (p=0.718).

Participants’ Socio-demographic characteristics.

VariableVariable sub-groupPostpartum group n=172Control group n=172
FrequencyPercentage (%)FrequencyPercentage (%)
Age (years)≤20158.784.7
Marital statusSingle74.13419.8
Educational statusNo formal education42.384.7

*African Traditional Religion

Following participants education on cervical cancer and its screening by Pap-test, all participants (100.0%, 172/172) in each group accepted to undertake the Pap-test.

The prevalence of SIL in the post partum group was 11.6% (20/172), while that of the control group was 10.5% (18/172). The observed difference was not statistically significant (OR: 1.8; 95% CI: 0.75-4.10; p=0.21). Similarly, there was no significant difference in the overall prevalence of abnormal cervical cytology (SIL plus Inflammatory cells) in the two groups [13.9% vs 12.1%; OR: 1.5; 95% CI: 0.62-2.40; p=0.18] [Table/Fig-2].

Prevalence and pattern of abnormal cervical cytology between the groups.

Abnormal cervical cytology categoryPostpartum groupControlp-valueOR (95% CI)
Frequency (%) (n=172)Frequency (%) (n=172)
Inflammatory Cells (IC)4 (2.3)3 (1.7)0.4220.9 (0.32-3.6)
SIL20 (11.6)18 (10.5)0.2131.8 (0.75-4.1)
ASCUS4 (2.3)3 (1.7)0.7111.4 (0.24-24)
LSIL9 (5.2)10 (5.8)0.6830.8 (0.12-3.4)
HSIL6 (3.5)5 (2.9)0.6010.6 (0.13-2.6)
AGC1 (0.6)0 (0.0)0.9230.7 (0.21-4.7)
IC+SIL24 (13.9)21 (12.1)0.1811.5 (0.62-2.4)

SIL: Squamous intraepithelial neoplasia; ASCUS: Atypical squamous cells of undetermined significance; AGC: Atypical glandular cells; LSIL: Low grade squamous intraepithelial lesion; HSIL: High grade Squamous intraepithelial lesion


Women in Sub-Saharan Africa countries, including Nigeria have a worrisome high rate of cervical cancer- a public health problem that affects both the women’s health and family economy. Though this study primarily set out to compare the prevalence of abnormal Pap-test between women attending the post-natal clinics with those from gynaecology and family planning clinics, it is noteworthy that the baseline characteristics of participants showed poor uptake of Pap-test despite the relatively good awareness of cervical cancer and its screening methods, which are characteristic of the study environment and indeed of Nigeria [3-5]. Interestingly, this study found a total acceptance of Pap-test by participants in the post-natal clinics and gynaecology/family planning clinics after appropriate information which is similar to the 99.8% reported earlier from the general out-patient clinics of the study centre [4]. The high acceptability of Pap-test in this study strongly suggests that the post-natal and other women-centred out-patient clinics are good environment for the provision of the “Provider-Initiated Cervical Cancer Counselling And Testing (PICCT)”-a strategy proposed for all eligible women seeking health care in settings without coordinated cervical cancer screening program, and it involves cervical cancer information and screening with opt-out option [4,7,20].

The pregnancy state affects cervical cytology results because of a wide range of physiological changes involving the cervical endothelium/stroma [21] however, these changes should resolve after delivery which may be associated with the reported high spontaneous regression rate of pre-malignant cervical lesions after delivery [16]. This study found that the prevalence and pattern of abnormal cervical cytology among women attending the 6-weeks post-natal clinic were similar to that of non-pregnant women from other clinics which may suggest that the pregnancy-related cervical changes in the postpartum (Group A) women might have regressed spontaneously by the end of puerperium. The prevalence of SIL in both the post-natal and other non-pregnant women is comparable to the prevalence of 12.2% found by Chukwuali LI et al., in the study area- Enugu, Nigeria. [17] However, it is higher than the findings of other related studies [15,20-23], possibly due to differences in study population and heterogeneity in study design.

Furthermore, the patterns of abnormal cervical cytology in both groups were comparable, with LSIL being the most common SIL. This is similar to the findings of other studies from South-western Nigeria [23,24], and North-western Nigeria [15]. It, however, differed with studies from North-central Nigeria [22] and Pathum Thani Province Thailand [25], that found ASCUS as the most common type of abnormal cervical cytology in their study population. The prevalence of inflammatory cells in both groups of this study were remarkably low when compared to a prevalence of 52.5% reported by Audu BM et al., in Gombe, Northern Nigeria [26]. This obvious disparity of cervical inflammatory changes in the two populations may suggest a differing regional prevalence of reproductive tract infections, especially Chlamydia trachomatis [27], which calls for further studies. The results of this study would no doubt help redirect the policymakers in designing policies and strategies aimed at improving the uptake of Pap-test or other recommended cervical cancer screening methods, in sub-Saharan Africa [12].


This study assumed that pregnancy-associated glandular and stromal cervical changes had resolved at 6 weeks postpartum which might not be completely true; however, the effect of the residual changes on the pap-test results was likely minimal because of the similarity of their basic characteristics with those of the non-pregnant population. Another drawback to the study is the fact that the study was based in one centre and, as such, might limit the generalisation of its results to the entire population.


The acceptability of cervical cytology at six weeks post-natal visit was very high and comparable with that of non-pregnant women in Enugu, Nigeria. Also, the prevalence and pattern of abnormal cervical cytology for women at six weeks post-natal clinic visit were comparable with the non-pregnant population. Therefore, the post-natal clinic visits at six weeks postpartum could provide a great opportunity for routine provider-initiated cervical cancer counselling and testing in Nigeria and similar resource-poor settings that lack organised cervical cancer screening program.

Declaration: The abstract of this study (FCS 11.653) was presented orally at the International Federation of Gynecology and Obstetrics (FIGO) XXII World Congress 2018 at Rio deJaneiro Brazil.

*African Traditional ReligionSIL: Squamous intraepithelial neoplasia; ASCUS: Atypical squamous cells of undetermined significance; AGC: Atypical glandular cells; LSIL: Low grade squamous intraepithelial lesion; HSIL: High grade Squamous intraepithelial lesion


[1]Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pineros M, Global Cancer Observatory: Cancer Today 2018 Lyon, FranceInternational Agency for Research on Cancer[cited 2019 August 23]. Available from: https://gco.iarc.fr/today  [Google Scholar]

[2]World Health Organization (WHO). Cervical Cancer Screening in Developing Countries: Report of a WHO consultation. Geneva, WHO Press; 2002. [cited 2019 October 18]. Available at: http:/www.who.int/cancer/media/en/cancer_cervical_37321.pdf  [Google Scholar]

[3]Ayinde OA, Omigbodun AO, Ilesanmi AO, Awareness of cervical cancer, papanicolaou’s smear and its utilization among female undergraduates in Ibadan Afr J Reprod Health 2004 8(3):68-80.10.2307/358339417348326  [Google Scholar]  [CrossRef]  [PubMed]

[4]Dim CC, Nwagha UI, Ezegwui HU, Dim NR, The need to incorporate routine cervical cancer counselling and screening in the management of women at the outpatient clinics in Nigeria J Obstet Gynaecol 2009 29(8):754-56.10.3109/0144361090322532319821672  [Google Scholar]  [CrossRef]  [PubMed]

[5]Chigbu CO, Aniebue U, Why southeastern Nigerian women who are aware of cervical cancer screening do not go for cervical cancer screening Int J Gynecol Cancer 2011 21(7):1282-86.10.1097/IGC.0b013e31822bd13921946294  [Google Scholar]  [CrossRef]  [PubMed]

[6]Dim CC, Ekwe E, Madubuko T, Dim NR, Ezegwui HU, Improved awareness of Pap smear may not affect its use in Nigeria: A case study of female medical practitioners in Enugu, southeastern Nigeria Trans R Soc Trop Med Hyg 2009 103(8):852-54.10.1016/j.trstmh.2009.03.02019394990  [Google Scholar]  [CrossRef]  [PubMed]

[7]Dim CC, “Not My Portion” Syndrome: The bane of cervical cancer prevention and women’s health promotion in Nigeria 152nd Inaugural Lecture: University of Nigeria; lecture given 2019 June 20   [Google Scholar]

[8]WHO. Strengthening cervical cancer prevention and control: A WHO meeting report of GAVI-UNFPH-WHO meeting 1 Dec 2009, Geneva Switzerland 2010. [cited 2019 October 18]. Available from: http://apps.who.int/iris/bitstream/10665/70394/1/WHO_RHR_10.13_eng.pdf  [Google Scholar]

[9]Bradley J, Barone M, Mahe C, Lewis R, Luciani S, Delivering cervical cancer prevention services in low-rei settings Int J Gynecol Obstet 2005 89(Suppl 2):S21-29.10.1016/j.ijgo.2005.01.01315823263  [Google Scholar]  [CrossRef]  [PubMed]

[10]Gakidou E, Nordhagen S, Obermeyer Z, Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities PLoS Med 2008 5(6):e13210.1371/journal.pmed.005013218563963  [Google Scholar]  [CrossRef]  [PubMed]

[11]Sowemimo OO, Ojo OO, Fasubaa OB, Cervical cancer screening and practice in low rei countries: Nigeria as a case study Trop J Obstet Gynaecol 2017 34(3):170-76.10.4103/TJOG.TJOG_66_17  [Google Scholar]  [CrossRef]

[12]WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. 2014. [cited 2019 May 23]. Available from: https://screening.iarc.fr/doc/9789241506779_eng.pdf  [Google Scholar]

[13]Nygard M, Daltveit AK, Thoresen SO, Nygard JF, Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: A population-based prospective study BMC Health Serv Res 2007 7:1010.1186/1472-6963-7-1017244348  [Google Scholar]  [CrossRef]  [PubMed]

[14]Londo R, Bjelland T, Girod C, Glasser M, Prenatal and postpartum Pap smears: Do we need both? Fam Pract Res J 1994 14(4):359-67.  [Google Scholar]

[15]Bakari F, Abdul MA, Ahmed SA, The prevalence and course of preinvasive cervical lesions during pregnancy in a northern Nigerian teaching hospital Ann Afr Med 2017 16(2):74-80.10.4103/aam.aam_35_1628469121  [Google Scholar]  [CrossRef]  [PubMed]

[16]Mailath-Pokorny M, Schwameis R, Grimm C, Reinthaller A, Polterauer S, Natural history of cervical intraepithelial neoplasia in pregnancy: Postpartum histopathologic outcome and review of the literature BMC Pregnancy and Childbirth 2016 16:7410.1186/s12884-016-0861-827055819  [Google Scholar]  [CrossRef]  [PubMed]

[17]Chukwuali LI, Onuigbo WIB, Mgbor NC, Cervical cancer screening in Enugu, Nigeria Trop J Obstet Gynecol 2003 20(2):109-12.10.4314/tjog.v20i2.14412  [Google Scholar]  [CrossRef]

[18]Dim CC, Ezegwui HU, Ikeme AC, Nwagha UI, Onyedum CC, Prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Enugu, South-eastern Nigeria J Obstet Gynaecol 2011 31(8):759-62.10.3109/01443615.2011.59896722085071  [Google Scholar]  [CrossRef]  [PubMed]

[19]Ugwu EO, Obi SN, Ezechukwu PC, Okafor II, Ugwu AO, Acceptability of human papillomavirus vaccine and cervical cancer screening among female health-care workers in Enugu, Southeast Nigeria Niger J Clin Pract 2013 16(2):249-52.10.4103/1119-3077.11014123563471  [Google Scholar]  [CrossRef]  [PubMed]

[20]Dim CC, Onyedum CC, Dim NR, Chukwuka JC, Cervical cancer screening among HIV-positive women in Nigeria: An assessment of use and willingness to pay in the absence of donor support J Int Assoc Provid AIDS Care 2015 14(2):241-44.10.1177/232595741348819123722087  [Google Scholar]  [CrossRef]  [PubMed]

[21]Michael CW, Esfahani FM, Pregnancy-related changes: A retrospective review of 278 cervical smears Diagn Cytopathol 1997 17(2):99-107.10.1002/(SICI)1097-0339(199708)17:2<99::AID-DC4>3.0.CO;2-J  [Google Scholar]  [CrossRef]

[22]Schnatz PF, Markelova NV, Holmes D, Mandavilli SR, O’Sullivan DM, The prevalence of cervical HPV and cytological abnormalities in association with reproductive factors of rural Nigerian women J Womens Health (Larchmt) 2008 17(2):279-85.10.1089/jwh.2006.029518321179  [Google Scholar]  [CrossRef]  [PubMed]

[23]Anorlu RI, Igwilo CI, Akanmu AS, Banjo AA, Odunukwe NN, Okany CC, Prevalence of abnormal cervical smears among patients with HIV in Lagos, Nigeria West Afr J Med 2007 26(2):143-47.  [Google Scholar]

[24]Thomas JO, Ojemakinde KO, Ajayi IO, Omigbodun AO, Fawole OI, Oladepo O, Population-based prevalence of abnormal cervical cytology findings and local risk factors in Ibadan, Nigeria: Implications for cervical cancer control programs and human papilloma virus immunization Acta Cytol 2012 56(3):251-58.10.1159/00033744422555526  [Google Scholar]  [CrossRef]  [PubMed]

[25]Suwannarurk K, Bhamarapravatana K, Thaweekul Y, Mairaing K, Poomtavorn Y, Pattaraarchachai J, A 1-year experience with liquid-based and conventional papanicolaou smear in Thammasat University Hospital J Med Assoc Thai 2011 94(Suppl 7):S47-51.  [Google Scholar]

[26]Audu BM, Elnafaty AU, Pindiga HU, Prevalence of abnormal cervical smears from sporadic screening in a gynaecological clinic The Nigerian Medical Practitioner 2007 51(6):114-18.10.4314/nmp.v51i6.28855  [Google Scholar]  [CrossRef]

[27]Wilson JD, Robinson AJ, Kinghorn SA, Hicks DA, Implications of inflammatory changes on cervical cytology BMJ 1990 300(6725):638-40.10.1136/bmj.300.6725.6382322699  [Google Scholar]  [CrossRef]  [PubMed]